Search Images Maps Play YouTube News Gmail Drive More »
Sign in
Screen reader users: click this link for accessible mode. Accessible mode has the same essential features but works better with your reader.

Patents

  1. Advanced Patent Search
Publication numberUSRE32034 E
Publication typeGrant
Application numberUS 06/632,152
Publication dateNov 19, 1985
Filing dateJul 18, 1984
Priority dateDec 19, 1977
Publication number06632152, 632152, US RE32034 E, US RE32034E, US-E-RE32034, USRE32034 E, USRE32034E
InventorsJohn C. Chabala, Michael H. Fisher, Helmut H. Mrozik
Original AssigneeMerck & Co., Inc.
Export CitationBiBTeX, EndNote, RefMan
External Links: USPTO, USPTO Assignment, Espacenet
13-Halo and 13-deoxy derivatives of C-076 compounds
US RE32034 E
Abstract
Derivatives of the C-076 compounds are disclosed wherein the 13-position is unsubstituted. The compounds are prepared by removing the glycosyl groups on the 13-position of the C-076 compounds isolated from the fermentation broth of Streptomyces avermitilis, followed by halogenation and subsequent removal of the halogen. The disclosed compounds are antiparasitic, anthelmintic, insecticidal and acaricidal agents.
Images(15)
Previous page
Next page
Claims(18)
What is claimed is:
1. A compound having the formula: ##STR4## wherein the broken line indicates a single or a double bond; R1 is hydrogen or halogen;
R2 is hydrogen, methyl or loweralkanoyl;
R3 is .[.n-propyl.]. .Iadd.isopropyl .Iaddend.or sec-butyl; and
R4 is present only when the broken line indicates a single bond and represents hydrogen, hydroxy, loweralkanoyloxy, loweralkylthio, loweralkylsulfinyl, loweralkylsulfonyl or loweralkoxy;
provided that when R2 is hydrogen or methyl the broken line can indicate only a single bond and R4 is other than hydroxy.
2. The compound of claim 1 wherein R3 is .[.n-propyl.]. .Iadd.isopropyl.Iaddend..
3. The compound of claim 1 wherein R3 is sec-butyl.
4. The compound of claim 3 wherein the broken line indicates a single bond and R4 is hydrogen.
5. The compound off claim 4 wherein R1 is chlorine, R2 is hydrogen, R3 is sec-butyl, R4 is hydrogen, and the broken line indicates a single bond, which is 13-chloro-13-deoxy-22,23, dihydro-C-076-B1a-aglycone.
6. The compound of claim 4 wherein R1 is hydrogen, R2 is hydrogen, R3 is sec-butyl, R4 is hydrogen, and the broken line indicates a single bond, which is 13-deoxy-22,23-dihydro-C-076-B1a-aglycone.
7. The compound of claim 4 wherein R1 is hydrogen, R2 is methyl, R3 is sec-butyl, R4 is hydrogen and the broken line indicates a single bond, which is 13-deoxy-22,23-dihydro-C-076-A1a-aglycone.
8. The compound of claim 3 wherein R2 is a loweralkanoyl.
9. The compound of claim 8 wherein R1 is chlorine, R2 is acetyl, R3 is sec-butyl, and R4 and the broken line represent a 22,23-double bond, which is 13-chloro-13-deoxy-C-076 B1a aglycone-5-O-acetate.
10. The compound of claim 8 wherein R1 is hydrogen, R2 is acetyl, R3 is sec-butyl and R4 and the broken line indicate a 22,23-double bond, which is 13-deoxy-C-076-B1a-aglycone-5-O-acetate.
11. The compound of claim 3 wherein R4 is loweralkanoyloxy.
12. The compound of claim 11 wherein R4 is an acetoxy group.
13. The compound of claim 12 wherein R1 is chlorine, R2 is hydrogen, R3 is sec-butyl, R4 is acetoxy, and the broken line indicates a single bond, which is 13-chloro-13-deoxy-C-076-B2a-aglycone 23-O-acetate.
14. The compound of claim 12 wherein R1 is hydrogen, R2 is hydrogen, R3 is sec-butyl, R4 is acetoxy, and the broken line indicates a single bond, which is 13-deoxy-C-076-B2a-aglycone 23-O-acetate.
15. The compound of claim 3 wherein R2 is loweralkanoyl, and R4 is loweralkanoyloxy.
16. The compound of claim 15 wherein R2 is acetate and R4 is acetoxy.
17. The compound of claim 16 wherein R1 is chlorine, R2 is acetyl R3 is sec-butyl, R4 is acetoxy, and the broken line indicates a single bond, which is 13-chloro-13-deoxy-C-076-B2a-aglycone 5,23-di-O-acetate.
18. The compound of claim 16 wherein R1 is hydrogen, R2 is acetyl, R3 is sec-butyl, R4 is acetoxy, and the broken line indicates a single bond, which is 13-deoxy-C-076-B2a-aglycone 5,23-di-O-acetate.
Description
BACKGROUND OF THE INVENTION

C-076 is a series of macrolides with potent antiparasitic activity. The compounds are isolated from the fermentation broth of Streptomyces avermitilis and the morphological characteristics of the microorganism as well as the methods employed to isolate the C-076 compounds are full described in U.S. Patent Application Ser. No. 772,061.

SUMMARY OF THE INVENTION

This invention is concerned with derivatives of the C-076 compounds. Specifically, it is concerned with C-076 derivatives which are unsubstituted at the 13-position. In addition various other positions of the C-076 compounds may be substituted. Thus, it is an object of this invention to describe the 13-deoxy compounds of this invention. It is a further object of this invention to describe various derivatives of said 13-deoxy-C-076 compounds. A still further object is to describe processes for the preparation of such compounds. A still further object is to describe methods and compositions using such compounds as the active ingredient in the treatment of parasitic infections. Further objects will be apparent from a reading of the following description.

DESCRIPTION OF THE INVENTION

The C-076 compounds which are the starting materials for the preparation of the instant compounds are best described in the following structural formula: ##STR1## wherein R is the α-L-oleandrosyl-α-L-oleandrose group of the structure: ##STR2## and wherein the broken line indicates a single or double bond; R1 is hydroxy and present only when said broken line indicates a single bond;

R2 is .[.n-propyl.]. .Iadd.isopropyl .Iaddend.or sec-butyl; and

R3 is methoxy or hydroxy.

With reference to the foregoing structural formula, the individual C-076 compounds are identified as follows:

______________________________________C-076   R1    R2           R3______________________________________A1a     Double bond              sec-butyl         --OCH3A1b     Double bond               .[.n-propyl.].                         .Iadd.isopropyl.Iaddend.                                --OCH3A2a     --OH       sec-butyl         --OCH3A2b     --OH       .[.n-propyl.].                         .Iadd.isopropyl.Iaddend.                                --OCH3B1a     Double bond              sec-butyl         --OHB1b     Double bond               .[.n-propyl.].                         .Iadd.isopropyl.Iaddend.                                --OHB2a     --OH       sec-butyl         --OHB2b     --OH       .[.n-propyl.].                         .Iadd.isopropyl.Iaddend.                                --OH______________________________________

Based on taxonomic studies, the microorganisms capable of producing these C-076 compounds are of a new species of the genus Streptomyces, which has been named Streptomyces avermitilis. One such culture, isolated from soil is designated MA-4680 in the culture collection of Merck & Co. Inc., Rahway, N.J. A C-076 producing sample of this culture has been deposited in the permanent culture collection of the Fermentation Section of the Northern Utilization Research Branch, U.S. Department of Agriculture at Peoria, Ill., and has been assigned the accession number NRRL 8165. A sample of NRRL 8165 has also been deposited, without restriction as to availability, in the permanent culture collection of the American Type Culture Collection at 12301 Parklawn Drive, Rockville, Md. 20852, and has been assigned the accession number ATCC 31,267.

The above microorganism is illustrative of a strain of Streptomyces avermitilis which can be employed in the production of the C-076 compounds. However, such description also embraces mutants of the above described microorganism. For example, those C-076 producing mutants which are obtained by natural selection or those producted by mutating agents including X-ray irradiation, ultraviolet irradiation, nitrogen mustard or like treatments are also included within the ambit of this invention.

One example of such an organism is a strain of Streptomyces avermitilis MA 4848 which was isolated after irradiation with ultraviolet light of Streptomyces avermitilis MA 4680. A lyophilized tube and a frozen vial of this culture has been deposited in the permanent culture collection of the American Type Culture Collection, and they have been assigned the accession numbers 31272 and 31271 respectively. Slightly higher fermentation yields of C-076 have been obtained using this frozen stock as inoculum.

The compounds of the instant invention are derived from the above C-076 compounds by removing the α-L-oleandrosyl-α-L-oleandrose group and also the hydroxy group at the 13-position that remains after the disaccharide is removed. In addition, other derivatization of the 13-deoxy C-076 compounds is possible such as acylation of one or more of the available hydroxy groups, reduction of the 22,23 double bond, alkylation of the hydroxy groups, substitution of an alkylthio group at the 23-position, and oxidized variations thereof, as well as the 13-halogenated compounds, which are intermediates in the preparation of the 13-deoxy compounds.

The compounds of the instant invention have the following structural formula: ##STR3## wherein the broken line indicates a single or double bond; R1 is hydrogen or halogen;

R2 is hydrogen, methyl or loweralkanoyl;

R3 is .[.n-propyl.]. .Iadd.isopropyl .Iaddend.or sec-butyl; and

R4 is present only when the broken line indicates a single bond and represents hydrogen, hydroxy, loweralkanoyloxy, loweralkylthio, loweralkylsulfinyl, loweralkylsulfonyl or loweralkoxy;

provided that when R2 is hydrogen or methyl, the broken line can indicate only a single bond and R4 is other than hydroxy.

In the instant invention the term "loweralkoxy" is intended to include those alkoxy groups containing from 1 to 6 carbon atoms in either a straight or branched configuration. Examples are methoxy, ethoxy, propoxy, iso-propoxy, butoxy, tert-butoxy, pentoxy, hexoxy and the like.

The terms "loweralkylthio," "loweralkylsulfinyl" and "loweralkylsulfonyl" are intended to include those thio, sulfinyl, and sulfonyl groups which contain a lower alkyl group of from 1 to 6 carbon atoms in either a straight or branched chain. Examples are methyl, ethyl, propyl, iso-propyl, butyl, sec-butyl, pentyl, hexyl and the like.

The terms "loweralkanoyl" or "loweralkanoyloxy" are intended to include those alkanoyl groups or those alkanoyloxy groups which contain from 2 to 6 carbon atoms in either a straight or branched configuration. Examples are acetyl, propionyl, butyryl, pentanoyl, hexanoyl, pivaloyl and the like.

The term "halogen" or "halo" is intended to include the halogen atoms of fluorine, chlorine, bromine and iodine.

The compounds of the instant invention are prepared by a series of reactions which converts the C-076 starting materials from a 13-disaccharide series of compounds to the aglycone compound (13-position is hydroxy) followed by the conversion of the 13-hydroxy group to the 13-halogen and 13-deoxy groups. In addition, the R2 and R4 substituent groups and the 22,23-unsaturation are reacted to form other substituents.

As is readily apparent from an analysis of the structure of the C-076 starting materials, there are five unsaturations in the 1-series of compounds. An object of the instant invention is to reduce the 22,23-double bond while not affecting the remaining four unsaturations or any other functional group present on the molecule. It is necessary to select a specific catalyst for the hydrogenation, one that will selectively hydrogenate the least hindered from among a series of unsaturations. The preferred catalyst for such a selective hydrogenation procedure is one having the formula:

[(R5)3 P]3 RhX

wherein R5 is loweralkyl, phenyl, or loweralkyl substituted phenyl and X is a halogen.

In the preferred catalyst R5 is phenyl and X is chlorine, that is the compound tris(triphenylphosphine)rhodium(I)chloride, which is also known as Wilkinson's homogeneous catalyst.

The reaction is carried out using a catalytic amount of the catalyst. The amount of catalyst is not critical and from 0.05 to 0.5 moles of the catalyst for each mole of starting material have been successfully employed. Molar ratios in the range of 0.25 to 0.40 are preferred.

The hydrogenation is carried out in a hydrogen atmosphere which may be either at atmospheric pressure or up to about 4 atmospheres pressure in a standard laboratory hydrogenation apparatus. A solvent is employed to dissolve both the starting materials and the catalyst. Preferred solvents are hydrocarbon solvents such as benzene, toluene, petroleum ether and other alkane hydrocarbons. The reaction is complete when the calculated amount of hydrogen has been taken up by the reaction. This will generally require from about 16 to 48 hours. The reaction may be carried out at from room temperature to about 75 C., however, room temperature is preferred. The hydrogenation products are isolated and purified by techniques known to those skilled in the art.

Other reactions may be carried out on the C-076 starting materials or on the hydrogenated products to prepare other compounds of this invention. While it is possible to complete other reactions on the C-076 starting material and have the hydrogenation step as the final reaction, it is preferred to carry out the hydrogenation step before the reactions at the 5- or 13-position. Because the 22,23-double bond is somewhat susceptible to electrophilic addition, reaction conditions for removing the sugar groups or acylating the hydroxy groups must be carefully controlled if the 22,23-double bond is present. If the 22,23-double bond is hydrogenated first, the other reactions are rendered more facile.

The acylated compounds at the 5- and 23-positions (R2 or R4 as loweralkanoyl) are prepared using acylation techniques in which the reaction conditions will vary, depending upon the reactivity of the hydroxy group being acylated. Where there is more than one hydroxy group to be acylated, different reaction conditions are employed to minimize the formation of mixtures.

The preferred acylation reagents employed are generally the loweralkanoyl halide, preferably the chloride, or the loweralkanoyl anhydride.

In the case of reactions carried out with the halide reagents, it is often advantageous to include in the reaction mixture a basic compound capable of reacting with and neutralizing the hydrogen halide which is liberated during the course of the reaction. Tertiary amines are preferred such as triethylamine, pyridine, 4-dimethylamino pyridine, diisopropyl ethylamine and the like. The basic compound is required in equimolar amounts relative to the number of moles of hydrogen halide being liberated, however excess amounts, even using the basic compound as a solvent, are not detrimental.

In the case of the A1 aglycone compounds, there are no hydroxy groups which may be acylated.

The A2 compounds have a single available hydroxy group at the 23-position capable of being acylated.

The 23-acyl compound may be prepared by heating the reaction mixture at from about room temperature to 100 C. for from 1 to 24 hours.

The B1 compounds also have a single available hydroxy group: at the 5-position. The reaction with the acylating agent is carried out in pyridine from about 0 C. to room temperature for from 4 to 24 hours. To recover the acylated compounds, the reaction mixture is eluted through a chromatographic column or a preparative layer chromatographic plate of alumina or silica gel and the purified compounds are readily isolated. In addition, other techniques, such as high pressure liquid chromatography, may be employed.

The B2 compounds have two hydroxy groups available for substitution: and 5-and 23-positions. the 5,23-diacyl compound may be prepared by carrying out the reaction at from room temperature to 100 C. for from 1-24 hours. The 5-acyl compound may be prepared by carrying out the reaction at from about 0 C. to room temperature for from 4-24 hours. To prepare the 23-acyl compound, the 5,23-diacyl compound is hydrolyzed with an aqueous base such as aqueous sodium hydroxide, at about room temperature for from 1 to 24 hours. The 5-acyl group will be hydrolyzed, leaving the 23-monoacyl compound.

The above described acyl compounds are isolated from the reaction mixture using techniques known to those skilled in this art.

The compounds where the 23-substituent (R4) is loweralkoxy or loweralkylthio are prepared from the 1-series of compounds (the compounds with a 22,23-unsaturation). This unsaturation is more readily susceptable to electrophilic addition than the other unsaturations in the molecule, thus by monitoring reaction conditions carefully, the reaction can be made fairly specific.

The reaction is carried out in the presence of an acid and a loweralkanol or a loweralkylthiol. The reaction may be carried out in an inert, aprotic solvent such as dioxane, tetrahydrofuran, ether and the like or if the alcohol or thiol is available in sufficient quantities, then said alcohol or thiol may be used in large excess and the inert solvent dispensed with. Suitable acids are sulfuric, hydrohalic, phosphoric, trifluoroacetic, trifluoromethanesulfonic, and the like. The preferred hydrohalic acid is hydrochloric or hydrobromic. The most preferred acid is sulfuric acid. The acid is present in the reaction mixture at from about 0.1 to 10% by weight. The reaction is complete generally at from 0-50 C. for from 2 to 24 hours. It is preferred to stir the reaction mixture overnight at room temperature.

Occasionally, to a small extent, there may be found some 22-addition products in the reaction mixture. This will be a minor side product, since the 23-substituent is the thermodynamically preferred compound, and the impurity is readily removed by chromatographic separation.

The 23-loweralkylthio substituent is oxidized to the 23-loweralkylsulfinyl and 23-loweralkylsulfonyl group with a mild oxidizing agent. The preferred oxidizing agent is m-chloroperbenzoic acid and the reaction is generally carried out in a solvent inert to oxidation. Halogenated hydrocarbons such as methylene chloride or chloroform are suitable. To prepare the sulfoxide a single molar equivalent of the oxidizing agent is employed and the reaction is complete in about 5 minutes to 1 hour at from -20 C. to room temperature. To prepare the sulfone two equivalents of the oxidizing agent are used and the reaction is complete in about 1-24 hours at from 0 C. to room temperature. The products are isolated using techniques known to those skilled in this art.

The 13-position substituents (R1 =halogen, hydrogen) are prepared from the C-076 starting materials as described hereinbelow. The reaction at the 13-position can generally be carried either before or after the other above described reactions.

The series of reactions at the 13-position commences with the removal of the α-L-oleandrosyl-α-L-oleandrose side chain which is found in the C-076 starting materials. This reaction produces what is identified as the "C-076 aglycone" compounds characterized by having a hydroxy group at the 13-position. The C-076 aglycone compounds are then halogenated with a suitably reactive benzenesulfonyl chloride or bromide in the presence of a base to produce the "13-deoxy-13-halo-C-076-aglycone" compounds. The halogen is then removed in a reaction with a trialkyltinhydride to produce the "13-deoxy-C-076 aglycone compounds."

The reaction conditions which are generally applicable to the preparation of C-076 aglycone involve dissolving the C-076 compound in an aqueous non-nucleophilic organic solvent, miscible with water, preferably dioxane, tetrahydrofuran, dimethoxyethane, dimethyl formamide, bis-2-methoxyethyl ether and the like, in which the water concentration is from 0.1 to 20% by volume. Acid is added to the aqueous organic solvent to the extent of 1.0 to 10% by volume. The reaction mixture is generally stirred at about 20-40 C., preferably at room temperature, for from 6 to 24 hours. The products are isolated, and mixtures are separated by techniques such as column, thin layer, preparative layer and high pressure liquid chromatography, and other known techniques.

The acids which may be employed in the above process include mineral acids and organic acids such as sulfuric, hydrohalic, phosphoric, trifluoroacetic, trifluoromethanesulfonic and the like. The hydrohalic acids are preferably hydrochloric or hydrobromic. The preferred acid in the above process in sulfuric acid.

A further procedure for the preparation of the aglycone compounds is applicable to all of the C-076 compounds, however, it is preferred for use on the compounds wherein the broken line indicates a single bond, since some degree of addition to the 22,23-double bond is noticed in those compounds with the 22,23-unsaturation. The procedure for the preparation of the aglycone, 1% sulfuric acid, by volume, in methanol at from 20-40 C., preferably room temperature, for from 6-24 hours has been found to be appropriate.

The other acids listed above may also be employed for this process, at approximately the concentration employed for sulfuric acid.

The above described compounds are isolated from the reaction mixture and mixtures of compounds are separated using techniques known to those skilled in this art, and in particular the chromatographic techniques described above.

The "C-076 aglycone" thus produced is then halogenated to produce the 13-deoxy-13-halo-C-076 aglycone. The halogenation is most readily carried out in the presence of a sufficiently reactive benzenesulfonylhalide compound in the presence of a base. The presence of electron withdrawing substituents on the benzenesulfonylhalide is advantageous and o-nitro substitution is preferred. The reaction is carried out in a non-protic inert solvent such as a halogenated alkyl compound, preferably methylene chloride or chloroform. The reactants are combined slowly at an initial temperature of from -25 to +10 C. to control any initial exothermic reactions and is maintained at this temperature for up to 2 hours. The reaction temperature is then raised to from about room temperature to the reflux temperature of the reaction mixture for from 10 minutes to 6 hours. It is necessary to carry out the reaction in the presence of a base, preferably an organic amine. It has been found to be preferable to employ the combination of a 4-diloweralkylamino pyridine and trialkylamine. It is most preferred to employ 4-dimethylamino pyridine and diisopropylethylamine as bases for the foregoing reactions. The 13-deoxy-13-halo-C-076 aglycone compounds are isolated by procedures known to those skilled in this art.

In order to avoid unwanted side-reactions, it is important that, in those C-076 compounds with a hydroxy group at the 5-position (the B-series of compounds), and to a lesser extent, the 23-hydroxy group of the 2-series of compounds, said hydroxy groups be protected. The protecting group is ideally one which may be readily synthesized, will not be affected by the reaction to alter the 13-position substituent, and may be readily removed wthout affecting any other function of the molecule. One preferred type of protecting group for the C-076 type of molecule is the trisubstituted silyl group, preferably a trialkylsilyl group. One preferred example is the tert-butyldimethylsilyl group. The reaction is carried out by reacting the hydroxy compound with the appropriately substituted silyl halide, preferably the silyl chloride, in an aprotic polar solvent such as dimethylformamide. Imidazole is added as a catalyst. The reaction is complete in from 1/2 to 24 hours at from 0-25 C. For the 5-position hydroxy group of the reaction is complete in about 1/2 to 3 hours at from 0 C. to room temperature. The silylation reaction is much slower at the 23-position hydroxy group (the 2-series of compounds), then at the 5-position hydroxy group, and protection is generally not necessary. However, if it is desired to protect the 23-hydroxy group, the reaction will be complete in about 5 to 24 hours at from about room temperature to 75 C. This reaction is selective to the 5- and 23-positions under the conditions above described, and very little, if any, silylation is observed at the 13-position.

The silyl group may be removed after the 13-halogenation of the reaction may be deferred until after the 13-halo group is removed. The silyl group or groups are removed by stirring the silyl compound is methanol catalyzed by a catalytic amount of an acid, preferably a sulfonic acid such as p-toluenesulfonic acid. The reaction is complete in about 1 to 12 hours at from 0 to 50 C.

The 13-deoxy-13-halo-C-076 aglycone which may or may not have the silyl groups protecting the 5- and 23-hydroxy groups is then reduced to form the 13-deoxy-C-076 aglycone. The preferred reducing agent is one that will selectively remove the 13-halo group but will leave the remainder of the molecule untouched. One such reducing agent is a trialkyltinhydride, preferably tributyltinhydride. In addition it is preferable to include in the reaction mixture a free radical initiator since it is believed that the reaction proceeds through a free radical mechanism (not wishing to be bound by theory, however, other possible mechanisms are not excluded). Acceptable free radical initiators are varied and include peroxides, such as dibenzoyl peroxides; thiols in the presence of air; azodialkylnitriles such as azobisisobutyronitrile; ultraviolet light; heat and the like. The reaction conditions will vary depending upon the type of free radical initiator which is employed. For chemical initiators the reaction is complete in about 1 to 6 hours at from 60-120 C. The preferred reaction temperature is about 85 C. If heat is the initiating agent, higher temperatures are required, about 100-200 C. for from 1-6 hours. If ultraviolet light is employed, lower temperatures are preferred. Generally the reaction will be complete in from 1-6 hours at -25 to 50 C. in the presence of ultraviolet light. The trialkyltinhydride reaction is generally carried out with no solvent under a a blanket of nitrogen or other inert gas. The tin hydride compound is used in excess and becomes the solvent. If desired, however, an inert solvent such as benzene, toluene, xylene and the like could be employed. For obvious reasons, halogenated solvents cannot be employed. The products are isolated using procedures known to those skilled in this art.

Except for the csse of the 22,23-hydrogenation reaction and the silylation reaction above mentioned, there is no requirement that the above reactions be carried out in any particular order. No conflicting reactions, save for the above exceptions, are found in the foregoing series of reactions and a reaction at one particular position will not affect any substituent groups at another reaction.

The novel 13-halo- and 13-deoxy-C-076 compounds of this invention have significant parasiticidal activity as anthelmintics, ectoparasiticides, insecticides and acaricides, in human and animal health and in agriculture.

The disease or group of diseases described generally as helminthiasis is due to infection of an animal host with parasitic worms known as helminths. Helminthiasis is a prevalent and serious economic problem in domesticated animals such as swine, sheep, horses, cattle, goats, dogs, cats and poultry. Among the helminths, the group of worms described as nematodes causes widespread and often times serious infection in various species of animals. The most common genera of nematodes infecting the animals referred to above are Haemonchus, Trichostrongylus, Ostertagia, Nematodirus, Cooperia, Ascaris, Bunostomum, Oesophagostomum, Chabertia, Trichuris, Strongylus, Trichonema, Dictyocaulus, Capillaria, Heterakis, Toxocara, Ascaridia, Oxyuris, Ancylostoma, Uncinaria, Toxascaris and Parascaris. Certain of these, such as Nematodirus, Cooperia, and Oesphagostomum attack primarily the intestinal tract while others, such as Haemonchus and Ostertagia, are more prevalent in the stomach while still others such as Dictyocaulus are found in the lungs. Still other parasites may be located in other tissues and organs of the body such as the heart and blood vessels, subcutaneous and lymphatic tissue and the like. The parasitic infections known as helminthiases lead to anemia, malnutrition, weakness, weight loss, severe damage to the walls of the intestinal tract and other tissues and organs and, if left untreated, may result in death of the infected host. The 13-halo-and 13-deoxy-C-076 compounds of this invention have unexpectedly high activity against these parasites, and in addition are also active against Dirofilaria in dogs, Nematospiroides, Syphacia, Aspiculuris in rodents, arthropod ectoparasites of animals and birds such as ticks, mites, lice, fleas, blowfly, in sheep Lucillia sp., biting insects and such migrating diperous larvae as Hypoderma sp. in cattle, Gastrophilus in horses, and Cuterebra sp. in rodents.

The instant compounds are also useful against parasites which infect humans. The most common genera of parasites of the gastro-intestinal tract of man are Ancylostoma, Necator, Ascaris, Strongyloides, Trichinella, Capillaria, Trichuris, and Enterobius. Other medically important genera of parasites which are found in the blood or other tissues and organs outside the gastrointestinal tract are the filiarial worms such as Wuchereria, Brugia, Onchocerca and Loa, Dracunculus and extra intestinal stages of the intestinal worms Strogyloides and Trichinella. The compounds are also of value against arthropods parasitizing man, biting insects and other dipterous pests causing annoyance to man.

The compounds are also active against household pests such as the cockroach, Blatella sp., clothes moth, Tineola sp., carpet beetle, Attagenus sp., and the housefly Musca domestica.

The compounds are also useful against insect pests of stored grains such as Tribolium sp., Tenebrio sp. and of agricultural plants such as spider mites, (Tetranychus sp.), aphids, (Acyrthiosiphon sp.); against migratory orthopterans such as locusts and immature stages of insects living on plant tissue. The compounds are useful as a nematocide for the control of soil nematodes and plant parasites such as Meloidogyne spp. which may be of importance in agriculture.

These compounds may be administered orally in a unit dosage form such as a capsule, bolus or tablet, or as a liquid drench where used as an anthelmintic in mammals. The drench is normally a solution, suspension or dispersion of the active ingredient usually in water together with a suspending agent such as bentonite and a wetting agent or like excipient. Generally, the drenches also contain an antifoaming agent. Drench formulations generally contains from about 0.001 to 0.5% by weight of the active compound. Preferred drench formulations may contain from 0.01 to 0.1% by weight. The capsules and boluses comprise the active ingredient admixed with a carrier vehicle such as starch, talc, magnesium stearate, or di-calcium phosphate.

Where it is desired to administer the C-076 derivatives in a dry, solid unit dosage form, capsules, boluses or tablets containing the desired amount of active compound usually sre employed. These dosage forms are prepared by intimately and uniformly mixing the active ingredient with suitable finely divided diluents, fillers, disintegrating agents and/or binders such as starch, lactose, talc magnesium stearate, vegetable gums and the like. Such unit dosage formulations may be varied widely with respect to their total weight and content of the antiparasitic agent depending upon factors such as the type of host animal to be treated, the severity and type of infection and the weight of the host.

When the active compound is to be administered via an animal feedstuff, it is intimately dispersed in the feed or used as a top dressing or in the form of pellets which may then be added to the finished feed or optionally fed separately. Alternatively, the antiparasitic compounds of our invention may be administered to animals parenterally, for example, by intramuscular, intratracheal, or subcutaneous injection in which event the active ingredient is dissolved or dispersed in a liquid carrier vehicle. For parenteral administration, the active material is suitably admixed with an acceptable vehicle, preferably of the vegetable oil variety such as peanut oil, cotton seed oil and the like. Other parenteral vehicled such as organic preparation using solketal, glycerol, formal and aqueous parenteral formulations are also used. The active 13-halo- or 13-deoxy-C-076 compound or compounds are dissolved or suspended in the parenteral formulation for administration; such formulations generally contain from 0.005 to 5% by weight of the active compound.

Although the antiparasitic agents of this invention find their primary use in the treatment and/or prevention of helminthiasis, they are also useful in the prevention and treatment of diseases caused by other parasites, for example, arthropod parasites such as ticks, lice, fleas, mites and other biting insects in domesticated animals and poultry. They are also effective in treatment of parasitic diseases that occur in other animals including humans. The optimum amount to be employed for best results will, of course, depend upon the particular compound employed, the species of animal to be treated and the type and severity of parasitic infection or infestation. Generally good results are obtained with our novel compounds by the oral administration of from about 0.001 to 10 mg. per kg. of animal body weight, such total dose being given at one time or in divided doses over a relatively short period of time such as 1-5 days. With the preferred compounds of the invention, excellent control of such parasites is obtained in animals by administering from about 0.025 to 0.5 mg. per kg. of body weight in a single dose. Repeat treatments are given as required to combat re-infections and are dependent upon the species of parasite and the husbandry techniques being employed. The techniques for administering these materials to animals are known to those skilled in the veterinary field.

When the compounds described herein are administered as a component of the feed of the animals, or dissolved or suspended in the drinking water, compositions are provided in which the active compound or compounds are intimately dispersed in an inert carrier or diluent. By inert carrier is meant one that will not react with the antiparasitic agent and one that may be administered safely to animals. Preferably, a carrier for feed administration is one that is, or may be, an ingredient of the animal ration.

Suitable compositions include feed premixes or supplements in which the active ingredient is present in relatively large amounts and which are suitable for direct feeding to the animal or for addition to the feed either directly or after an intermediate dilution or blending step. Typical carriers or diluents suitable for such compositions include, for example, distillers' dried grains, corn meal, citrus meal, fermentation residues, ground oyster shells, wheat shorts, molasses solubles, corn cob meal, edible bean mill feed, soya grits, crushed limestone and the like. The active 13-halo or 13-deoxy-C-076 compounds are intimately dispersed throughout the carrier by methods such as grinding, stirring, milling or tumbling. Compositions containing from about 0.005 to 2.0% by weight of the active compound are particularly suitable as feed premixes. Feed supplements, which are fed directely to the animal, contain from about 0.0002 to 0.3% by weight of the active compounds.

Such supplements are added to the animal feed in an amount to give the finished feed the concentration of active compound desired for the treatment and control of parasitic diseases. Although the desired concentration of active compound will vary depending upon the factors previously mentioned as well as upon the particular C-076 derivative employed, the compounds of this invention are usually fed at concentrations of between 0.00001 to 0.002% in the feed in order to achieve the desired antiparasitic result.

In using the compounds of this invention, the individual 13-halo- and 13-deoxy-C-076 components may be prepared and used in that form. Alternatively, mixtures of two or more of the individual 13-halo- and 13-deoxy-C-076 components may be used, as well as mixtures of the parent C-076 compounds and the compounds of this invention.

In the isolation of the C-076 compounds, which serve as starting materials for the instant processes, from the fermentation broth, the various C-076 compounds will be found to have been prepared in unequal amounts. In particular an "a" series compound will be prepared in a higher proportion than the corresponding "b" series comound. The weight ratio of "a" series to the corresponding "b" series is about 85:15 to 99:1. The differences between the "a" series and "b" series is constant throughout the C-076 compounds and consists of an .[.n-butyl group and a sec-propyl.]. .Iadd.sec-butyl and isopropyl .Iaddend.group respectively at the 25-position. This difference, of course, does not interfere with any of the instant reactions. In particular, it may not be necessary to separate the "b" components from the related "a" component. Separation of these closely related compounds is generally not practiced since the "b" compound is present only in a very small percent by weight, and the structural difference has negligible effect on the reaction processes and biological activities.

The C-076 compounds of this invention are also useful in combatting agricultural pests that inflict damage upon crops while they are growing or while in storage. The compounds are applied using known techniques as sprays, dusts, emulsions and the like, to the growing or stored crops to effect protection from such agricultural pests.

The following examples are provided in order that this invention might be more fully understood; they are not to be construed as limitative of the invention.

The 13-halo- and 13-deoxy-C-076 derivatives prepared in the following examples are generally isolated as amorphous solids and not as crystalline solids. They are characterized analytically using techniques such as mass spectrometry, nuclear magnetic resonance, and the like. Being amorphous, the compounds are not characterized by sharp melting points, however, the chromatographic and analytical methods employed indicate that the compounds are pure.

EXAMPLE 1 23-O-t-Butyldimethylsilyl-C-076-A2a-Aglycone

200 Mg. of C-076-A2a-aglycone in 2.4 ml. of dry dimethylformamide is combined with 133 mg. of imidazole and stirred until all the omponents are dissolved. 146 Mg. of t-butyldimethylsilylchloride is added and the reaction mixture stirred at room temperature for 24 hours. The reaction mixture is diluted with ether and washed five times with water. The combined water washes are extracted with ether and the combined organic layers washed again with water, followed by a single wash with saturated sodium chloride solution. The ether layer is concentrated to dryness in vacuo affording 340 mg. of a gold colored oil. Preparative layer chromatography of the oil on two plates of silica gel eluting with a mixture of 5% tetrahydrofuran and 5% ethanol in methylene chloride affords 113.2 mg. of 23-O-t-butyldimethylsilyl-C-076-A2a-aglycone, the structure of which is confirmed by mass spectrometry, and nuclear magnetic resonance.

EXAMPLE 2 23-O-t-Butyldimethylsilyl-13-Chloro-13-Deoxy-C-076-A2a-Aglycone

20 Mg. of 23-O-t-butyldimethylsilyl-C-076-A2a-aglycone is combined with 0.7 ml. of a methylene chloride solution containing 15 mg. of 4-dimethylaminopyridine and 0.021 ml. (15.5 mg.) of diisopropylethylamine. The mixture is cooled in an ice bath and a solution of 0.1 ml. of methylene chloride containing 20 mg. of o-nitrobenzenesulfonylchloride is added dropwise. The reaction mixture is stirred for 45 minutes in an ice bath, and for 3 hours at room temperature. Ice chips are added to the reaction mixture and stirred. When the ice is melted ether is added to the mixture and the layers separated. The aqueous layer is again extracted with ether and the combined organic layers washed twice with water, dried over magnesium sulfate and evaporated to dryness under a stream of nitrogen affording 35 mg. of a gold film. Preparative layer chromatography of the material on a single silica gel plate eluting with 5% tetrahydrofuran and 5% ethanol in methylene chloride affords 10.1 mg. of 23-O-t-butyldimethylsilyl-13-chloro-13-deoxy-C- 076-A2a-Aglycone, the structure of which is confirmed by mass spectrometry and 300 MHz nuclear magnetic resonance.

EXAMPLE 3 13-Chloro-13-Deoxy-C-076-A2a-Aglycone

A solution of 10mg. of 23-O-t-butyldimethylsilyl-13-deoxy-C-076-A2a-aglycone in 1.0 ml. of methanol containing 1% p-toluene sulfonic acid dihydrate is stirred at room temperature for 5 hours. The reaction mixture is diluted with 25 ml. of ethyl acetate, and washed with aqueous sodium bicarbonate and water. The organic layer is dried and evaporated to dryness in vacuo affording 13-chloro-13-deoxy-C-076A2a-aglycone.

EXAMPLE 4 13-Chloro-13-Deoxy-C-076-A2a-Aglycone

20 Mg. of C-076-A2a-aglycone is dissolved in 0.7 ml. of methylene chloride containing 16 mg. of 4-dimethylaminopyridine and 16.8 mg. (0.023 ml.) of diisopropylethylamine. The reaction mixture is cooled in an ice bath and 0.1 ml. of methylene chloride containing 21.5 mg. of o-nitrobenzenesulfonylchloride is added dropwise. The reaction mixture is stirred in an ice bath for 1 hour, allowed to warm to room temperature and stirred for 4 hours. Ice is added and stirred until melted. Ether is added and the layers shaken and separated. The aqueous layer is extracted with ether and the organic layers combined, washed three times with water, dried over magnesium sulfate and evaporated to dryness under a stream of nitrogen affording 40 mg. of a brown film. Preparative layer chromatography on silica gel eluting with 3% tetrahydrofuran and 1% ethanol in methylene chloride affords 4.7 mg. of 13-chloro-13-deoxy-C-076-A2a-aglycone, which is identified by a nuclear magnetic resonance and mass spectrometry.

EXAMPLE 5 13-Deoxy-C-076-A2-a-Aglycone

80 Mg. 13-chloro-13-deoxy-C-076-A2a-aglycone is dissolved in 1.5 ml. of tributyltinhydride and 20 mg. of azobisisobutylronitrile is added. The reaction is heated under a blanket of nitrogen at 85 C. for 31/2 hours, cooled and placed on a silica gel preparative layer chromatography plate and eluted with chloroform affording 110 mg. of a glass. Repeated preparative layer chromatography on silica gel using methylene chloride with 2% tetrahydrofuran and 0.07% ethanol as eluent affords 70 mg. of a white glass which is identified by mass spectrometry and mHz nuclear magnetic resonance as 13-deoxy-C-076-A2a-aglycone.

EXAMPLE 6 5-O-t-Butyldimethylsilyl-C-076-B1a-Aglycone

100 Mg. of C-076-B1a-aglycone is dissolved in 1.2 ml. of anhydrous dimethylformamide and 46 mg. of imidazole is added followed by 50 mg. of t-butyldimethylsilylchloride. The reaction is maintained at 20 C. for 30 minutes and diluted with ether. The mixture is washed with water, dried and concentrated in vacuo to a colorless glass. Further purification on a preparative layer chromatography plate eluting with a methylene chloride, tetrahydrofuran mixture affords purified 5-O-t-butyldimethylsilyl-C-076-B1a-aglycone.

Following the above procedure, utilizing C-076-B2a-aglycone in place of C-076-B1a-aglycone, affords 5-O-t-butyldimethylsilyl-C-076-B2a-aglycone.

EXAMPLE 7 5-O-t-Butyldimethylsilyl-13-Deoxy-13-chloro-C-076-B1a-Aglycone

Following the procedure of Example 4 utilizing 5-O-t-butyldimethylsilyl-C-076-B1a-aglycone in place of C-076-A2a-aglycone, there is produced 5-O-t-butyldimethylsilyl-13-deoxy-13-chloro-C-076-B1a-aglycone.

Following the above referenced procedure using 5-O-t-butyldimethylsilyl-C-076-B2a-aglycone in place of 5-O-t-butyldimethylsilyl-C-076-B1a-aglycone, there is obtained 5-O-t-butyldimethylsilyl-13-deoxy-13-chloro-C-076-B2a-aglycone.

EXAMPLE 8 5-O-t-Butyldimethylsilyl-13-Deoxy-C-076-B1a-Aglycone

Following the procedure of Example 5 utilizing 5-O-t-butyldimethylsilyl-13-deoxy-13-chloro-C-076-B1a-aglycone in place of 13-chloro-13-deoxy-C-076-A2a-aglycone, there is produced 5-O-t-butylmethylsilyl-13-deoxy-C-076-B1a-aglycone.

Following the above referenced procedure using 5-O-t-butyldimethylsilyl-13-deoxy-13-chloro-C-076-B2a in place of 5-O-butyldimethylsilyl-13-deoxy-13-chloro-C-076-B1a-aglycone, there is produced 5-O-t-butyldimethylsilyl-13-deoxy-C-076-B2a-aglycone.

EXAMPLE 9 13-Deoxy-C-076-B1a-Aglycone

A solution of 13 mg. of 5-O-t-butyldimethylsilyl-13-deoxy-C-076-B1a-aglycone in 1.0 ml. of methanol containing 1% p-toluenesulfonic acid dihydrate is stirred at 20 C. for 3 hours. The reaction is diluted with 30 ml. of ethyl acetate, washed with aqueous sodium bicarbonate solution, and then with water. The organic layer is dried and evaporated to dryness in vacuo to afford 13-deoxy-C-076-B1a-aglycone as a clear glass.

Following the above procedure, utilizing 5-O-t-butyldimethylsilyl-13-deoxy-C-076-B2a-aglycone in place of 5-O-t-butyldimethylsilyl-13-deoxy-C-076-B1a-aglycone, there is obtained 13-deoxy-C-076-B2a-aglycone.

If the products of Example 7 are hydrolized according to the foregoing procedure, there will be obtained 13-chloro-13-deoxy-C-076-B1a-aglycone and 13-chloro-13-deoxy-C-076-B2a-aglycone.

EXAMPLE 10 13-Chloro-13-Deoxy-22,23-Dihydro-C-076-A1a-Aglycone

A solution of 8.2 mg. of 22,23-dihydro-C-076-A1a-aglycone and 0.35 ml. of methylene chloride containing 7.5 mg. of 4-dimethylaminopyridine and 10.5 microliters of diisopropylethylamine is cooled to 0 C. and treated with 10 mg. of o-nitrobenzenesulfonylchloride. After stirring for 1 hour at 0 C. the reaction is warmed to room temperature for 2 hours. The reaction mixture is quenched with ice and treated with 2 ml. of ether. The layers are separated and aqueous phase washed twice with 1 ml. of ether. The combined organic layers are washed twice with water, dried over sodium sulfate and evaporated to dryness in vacuo. The product is isolated by preparative layer chromatography on a single silica gel plate eluting with chloroform. Lyophilization of the residue affords 1.3 mg. of a white powder identified by mass spectrometry and nuclear magnetic resonance as 13-chloro-13-deoxy-22,23-dihydro-C-076-A1a-aglycone.

EXAMPLE 11 13-Deoxy-22,23-Dihydro-C-076-A1a-Alglycone

A solution of 1.0 mg. of 13-chloro-13-deoxy-22,23-dihydro-C-076-A1a-aglycone is dissolved in 0.2 ml. of tributyltinhydride containing 0.2 mg. of azobisisobutyronitrile and heated under nitrogen at 85 C. for 31/2 hours. The mixture is cooled and chromatographed on a single silica gel preparative layer chromatography plate eluting with chloroform. The remaining tributyltinhydride and tributyltinchloride move with the solvent front and the product is found at Rf of about 0.15 to 0.4. This band is collected and eluted from the silica gel with ethyl acetate. The mixture is chromatographed on a preparative layer silica gel chromatography plate eluting with chloroform affording 0.5 mg. of 13-deoxy-22,23-dihydro-C-076-A1a-aglycone identified by mass spectrometry and nuclear magnetic resonance.

EXAMPLE 12 5-O-t-Butyldimethylsilyl-22,23-Dihydro-C-076-B1a-Aglycone

50 mg. of 22,23-dihydro-C-076-B1a-aglycone is dissolved in 1.1 ml. of dimethylformamide containing 60 mg. imidazole. While under nitrogen 75 mg. of t-butyl-dimethylsilychloride is added and the stoppered mixture is stirred overnight at room temperature. The reaction is quenched with 2 ml. of water after dilution of the reaction mixture 15 ml. of ether. The aqueous phase is separated and extracted with 5 ml. of ether. The combined organic phases are washed 5 times with 10 ml. of water, the combined aqueous washes are extracted with 5 ml. of ether, and the combined organic phases washed once again with 5 ml. of water. The organic layer is dried over magnesium sulfate and evaporated to dryness in vacuo to an oil. The oil is chromatographed on 2 silica gel preparative layer chromatography plates eluting twice with methylene chloride. The slowest moving and most intense band is collected and washed from the silica gel with ethyl acetate. Lyophilization from benzene affords 36.3 mg. of a white powder identified by nuclear magnetic resonance and mass spectrometry as 5-O-t-butyldimethylsilyl-22,23-dihydro-C-76-B1a-aglycone.

EXAMPLE 13 13-Chloro-13-Deoxy-5-O-t-Butyldimethylsilyl-22,23-Dihydro-C-076-B1a-Aglycon

A solution of 35.5 mg. of 5-O-t-butyldimethylsilyl-22,23-dihydro-C-076-B1a-aglycone in 2.6 ml. of methylene chloride containing 56 mg. of 4-dimethylaminopyridine pyridine and 78 microliters (59 mg.) of diisopropylethylamine is cooled to 0 C. and treated with 75 mg. of o-nitrobenzenesulfonyl chloride. The reaction mixture is stirred for 1 hour at 0 C., allowed to warm to room temperature and stirred for 3 hours. 3 Ml. of crushed ice is added to the reaction mixture followed by 4 ml. of ether. The layers are separated and the aqueous phase washed with 4 ml. of ether and the combined organic phases washed twice with 5 ml. of water. The organic layer is dried over sodium sulfate and evaporated to dryness in vacuo. Benzene is added to the residue and azeotroped away. The product is isolated by preparative layer chromatography eluting with a 1:2 mixture of petroleum ether (b.p. 30 to 60 C.) and chloroform to afford 5.4 mg. of 13-chloro-13-deoxy-5-O-t-butyldimethylsilyl-22,23-dihydro-C-076-B1a-Aglycone identified by mass spectrometry and nuclear magnetic resonance.

EXAMPLE 14 13-Deoxy-5-O-t-Butyldimethylsilyl-22,23-Dihydro-C-076-B1a-Aglycone

A solution of 13.2 mg. of 13-chloro-13-deoxy-5-O-butyldimethylsilyl-22,23-dihydro-C-076-B1a-aglycone is combined with 0.7 ml. of tributyltinhydride and 2.0 mg. of azobisisobutyronitrile and heated to 85 C. for 31/2 hours under a blanket of nitrogen. The reaction mixture is cooled and dissolved in 1.5 ml. of methylene chloride and filtered through a column of silica gel eluting with methylene chloride. The tributyltinhydride and tributyltinchloride pass through the column upon washing with 250 ml. of methylene chloride and the product remains on the column. The solvent is changed to ethyl acetate and the product eluted at the solvent front. The ethyl acetate solution is concentrated to an oil and the product purified by preparative layer chromatography on silica gel plates eluting with a 1:1 mixture of petroleum ether (b.p. 30 to 60 C.) and methylene chloride to afford, after lyophilization from benzene, 8.2 mg. of 13-deoxy-5-O-t-butyldimethylsilyl-22,23-dihydro-C-076-B1a-aglycone which is identified by mass spectrometry and nuclear magnetic resonance.

EXAMPLE 15 13-Deoxy-22,23-Dihydro-C-076-B1a-Aglycone

A solution of 6.9 mg. of 13-deoxy-5-O-t-butyldimethylsilyl-22,23-dihydro-C-076-B1a-aglycone in 0.6 ml. of 1% p-toluenesulfonic acid in methanol is stirred for 3 hours at room temperature. The reaction is quenched with 5 ml. of ether and 1 ml. of saturated aqueous potassium bicarbonate. The layers are separated and the aqueous phase washed with 2 ml. of ether and the combined organic phases washed with water, dried over sodium sulfate and evaporated to dryness in vacuo. The oil is chromatographed on a single silica gel plate eluting with a 2:1 mixture of methylene chloride and petroleum ether (b.p. 30 to 60 C.). After lyophilization there remains 4.5 mg. of 13-deoxy-22,23-dihydro-C-076-B1-a-aglycone identified by mass spectrometry and nuclear magnetic resonance.

EXAMPLE 16 13-Deoxy-23-O-t-butyldimethylsilyl-C-076-A2a-aglycone

1 Mg. of 13-chloro-13-deoxy-23-O-t-butyldimethylsilyl-C-076-A2a-aglycone is dissolved in 50 microliters of toluene and 100 microliters of tributyltinhydride and 200 micrograms of azobisisobutyronitrile and heated at 60 C. for 4 hours. The product is isolated by direct chromatography on a preparative layer silica gel chromatography plate eluting with 1.5% tetrahydrofuran in chloroform affording 13-deoxy-23-O-t-butyldimethylsilyl-C-076-A2a-aglycone which is identified by mass spectrometry.

EXAMPLE 17 5-O-Acetyl-13-Chloro-13-Deoxy-C-076-B1a-Aglycone

25 Mg. of 13-chloro-13-deoxy-C-076-B1a-aglycone is dissolved in 0.6 ml. of pyridine and 0.3 ml. of acetic anhydride is added. The reaction is stirred at 20 C. overnight. Ice is added to the reaction mixture, allowed to melt, and extracted with ether. The ether layer is washed with water, dried and concentrated in vacuo. The residue is purified by preparative layer chromatography on silica gel, eluting with chloroform, and the structure of 5-O-acetyl-13-chloro-13-deoxy-C-076-B1a-aglycone is confirmed by mass spectrometry and nuclear magnetic resonance.

EXAMPLE 18 5-O-Acetyl-13-Deoxy-C-076-B1a-Aglycone

Following the procedure of Example 17 using 13-deoxy-C-076-B1a-aglycone in place of 13-chloro-13-deoxy-C-076-B1a-aglycone, there is obtained 5-O-acetyl-13-deoxy-C-076-B1a aglycone.

If propionic anhydride is employed in place of acetic anhydride in either of Examples 17 or 18, the analogous 5-O-propionyl compound is obtained.

EXAMPLE 19 5-O-t-Butyldimethylsilyl-13-Chloro-13-Deoxy-23-O-Acetyl-C-076-B2a-Aglycone

A mixture of 20 mg. of 5-O-t-butyldimethylsilyl-13-chloro-13-deoxy-C-076-B2a-aglycone, 0.8 ml. of pyridine and 0.4 ml. of acetic anhydride is heated in an oil bath for 2 hours at 100 C. The reaction mixture is cooled, ice is added, allowed to melt, and the precipitate collected by centrifugation. The solid material is dried, dissolved in methylene chloride and chromatographed on a preparative layer silica gel plate. The product is collected, dissolved in benzene and lyophilized affording 5-O-t-butyldimethylsilyl-13-chloro-13-deoxy-23-O-acetyl-C-076-B2a-aglycone as a white fluffy solid.

EXAMPLE 20 5-O-t-Butyldimethylsilyl-13-Deoxy-23-O-Acetyl-C-076-B2a-Aglycone

Following the procedure of Example 19 using 5-O-t-butyldimethylsilyl-13-deoxy-C-076-B2a-aglycone in place of 5-O-t-butyldimethylsilyl-13-chloro-13-deoxy-C-076-B2a-aglycone, there is obtained 5-O-t-butyldimethylsilyl-13-deoxy-23-O-acetyl-C-076-B2a-aglycone.

EXAMPLE 21 13-Chloro-13-Deoxy-23-O-Acetyl-C-076-B2a-Aglycone

10 Mg. of 5-O-t-butyldimethylsilyl-13-chloro-13-deoxy-23-O-acetyl-C-076-B2a-aglycone is dissolved in 0.5 ml. of methanol containing 1% by weight of p-toluenesulfonic acid dihydrate, and stirred at room temperature for 3 hours. To the reaction mixture is added 5 ml. of ether and the solution washed with aqueous sodium bicarbonate solution, dried and concentrated under a stream of nitrogen to a colorless glass. The glass is further purified by preparative layer chromatography on silica gel eluting with chloroform, and affording pure 13-Chloro-13-deoxy-23-O-acetyl-C-076-B2a-aglycone.

EXAMPLE 22 13-Deoxy-23-O-Acetyl-C-076-B2a-Aglycone

Following the procedure of Example 21 employing 5-O-t-butyldimethylsilyl-13-deoxy-23-O-acetyl-C-076-B2a-aglycone in place of 5-O-t-butyldimethylsilyl-13-chloro-13-deoxy-23-O-acetyl-C-076-B2a-aglycone, there is obtained 13-deoxy-23-O-acetyl-C-076-B2a-aglycone.

EXAMPLE 23 13-Chloro-13-Deoxy-5,23-Di-O-Acetyl-C-076-B2a-Aglycone

50 Mg. of 13-chloro-13-deoxy-C-076-B2a-aglycone is dissolved in 1 ml. of pyridine and 0.5 ml. of acetic anhydride is added. The reaction mixture is heated for 2 hours at 100 C. Upon cooling to room temperature, ice water is added, producing a precipitate which is collected by filtration. The solid material is further purified by preparative layer chromatography eluting with 2.1 tetrahydrofuran in chloroform affording pure 13-chloro-13-deoxy-5,23-di-O-acetyl-C-076-B2a-aglycone.

EXAMPLE 24 13-Deoxy-5,23-Di-O-Acetyl-C-076-B2a-Aglycone

Following the procedure of Example 23 using 13-deoxy-C-076-B2a-aglycone in place of 13-chloro-13-deoxy-C-076-B2a-aglycone, there is obtained 13-deoxy-5,23-di-O-acetyl-C-076-B2a-aglycone.

EXAMPLE 25 13-Deoxy-22,23-Dihydro-23-n-Butylthio-C-076-A1a-Aglycone

A solution of 100 mg. of 13-deoxy-C-076-A1a-aglycone in a mixture of 9.4 ml. of dioxane, 0.5 ml. of n-butanethiol and 0.1 ml. of concentrated sulfuric acid is stirred at 18 C. for 18 hours. The reaction mixture is diluted with 80 ml. of ether washed with aqueous sodium bicarbonate solution, dried and concentrated in vacuo to a light glass. The glass is further purified on a preparative layer chromatography silica gel plate. The product is identified by mass spectrometry and nuclear magnetic resonance as 13-deoxy-22,23-dihydro-23-n-butylthio-C-076-A1a-aglycone.

EXAMPLE 26

13-Chloro-13-Deoxy-22,23-Dihydro-23-n-Butylthio-C-076-A1a Aglycone

Following the procedure of Example 25 employing 13-chloro-13-deoxy-C-076-A1a-aglycone in place of 13-deoxy-C-076-A1a-aglycone, one obtains 13-chloro-13-deoxy-22,23-n-butylthio-C-076-A1a-aglycone.

EXAMPLE 27

Following Example 25 employing equivalent amounts of methanethiol, isopropylthiol and tert-butylthiol, there is obtained 13-deoxy-22,23-dihydro-23-methylthio-C-076-A1a-aglycone, 13-deoxy-22,23-dihydro-23-isopropylthio-C-076-A1a-aglycone and 13-deoxy-22,23-dihydro-23-tertbutylthio-C-076-A1a-aglycone.

EXAMPLE 28 13-Deoxy-22,23-Dihydro-23-n-Butylsulfinyl-C-076-A1a-Aglycone

A solution of 67 mg. (0.1 mmoles) of 13-deoxy-22,23-dihydro-23-n-butylthio-C-076-A1a-aglycone in 1.0 ml. of chloroform is stirred rapidly at 0 C. A second solution containing 19 mg. (0.11 mmoles) of m-chloro perbenzoic acid in 0.5 ml. of chloroform is added dropwise. The reaction mixture is allowed to reach 18 C., allowed to stand for 2 hours, then diluted with ether, washed with aqueous sodium bicarbonate solution, dried and concentrated under a stream of nitrogen to a colorless glass, which is identified as 13-deoxy-22,23-dihydro-23-n-butylsulfinyl-C-076-A1a-aglycone.

EXAMPLE 29 13-Deoxy-22,23-Dihydro-23-n-Butylsulfonyl-C-076-A1-Aglycone

Following the procedure of Example 28 employing twice the amount of m-chloro perbenzoic acid that is 38 mg. (0.22 mmoles) in 1.0 ml. of HCCl3, affords 13-deoxy-22,23-dihydro-23-n-butylsulfonyl-C-076-A1-aglycone.

EXAMPLE 30 13-Deoxy-22,23-Dihydro-23-Methoxy-C-076-B1a-Aglycone

A solution of 100 mg. of 13-deoxy-C-076-B1a-aglycone cone in a mixture of 9.9 ml. of methanol and 0.1 ml. of concentrated sulfuric acid is maintained at 18 C. for 20 hours. The reaction mixture is diluted with 100 ml. of ether and washed with aqueous sodium bicarbonate solution. The solution is dried and concentrated in vacuo to a glass. The reaction product is further purified on a preparative layer silica gel chromatography plate and identified by nuclear magnetic resonance and mass spectrometry as 13-deoxy-22,23-dihydro-23-methoxy-C-076-B1a-aglycone.

EXAMPLE 31

Following the procedure of Example 30 but using ethanol, isopropanol or n-hexanol in place of methanol, 13-deoxy-22,23-dihydro-23-ethoxy-C-076-B1a-aglycone; 13-deoxy-22,23-dihydro-23-isopropoxy-C-076-B1a-aglycone, and 13-deoxy-22,23-dihydro-23-n-hexyloxy-C-076-B1a-aglycone are obtained.

EXAMPLE 32 13-Chloro-13-Deoxy-22,23-Dihydro-23-Methoxy-C-076-B1a-Aglycone

Folowing the procedure of Example 30 employing 13-chloro-13-deoxy-C-076-B1a-aglycone in place of 13-deoxy-C-076-B1a-aglycone there is obtained 13-chloro-deoxy-22,23-dihydro-23-methoxy-C-076-B1a-aglycone.

PREPARATION 1 C-076 A1a-Aglycone

100 Mg. of C-076 A1 a is dissolved in 5 ml. of dioxane, stirred and added at room temperature to a mixture of 0.1 ml. of concentrated sulfuric acid, 1.9 ml. of methanol and 3.0 ml. of dioxane. The reaction mixture is stirred overnight at room temperature. 473 Mg. of solid sodium bicarbonate is added and the mixture stirred for 20 minutes. 3 Ml. of water is added and stirred for an additional 10 minutes. The reaction mixture is concentrated and 40 ml. of chloroform is added and shaken. The aqueous layer is separated and extracted with 5 ml. of chloroform. The organic layers are combined and washed once with dilute sodium chloride solution, dried over magnesium sulfate and evaporated to dryness in vacuo. 1/2 of the residue is placed on 5 perparative layer chromatography silica gel plates and eluted with 2% methanol in chloroform affording 4 bands of material. The remainder of the material was run on 2 preparative layer chromatography plates eluting with 2% methanol in chloroform affording 4 band similar to the first series. The second fastest bands are removed from each of the plates, combined, extracted and evaporated to dryness in vacuo, and rechromatographed on a preparative layer chromatography silica gel plate eluting with 3% tetrahydrofuran and chloroform affording 9.4 mg. of a fluffy white solid which is identified by mass spectrometry as C-076 -A1a-aglycone.

PREPARATION 2 C-076-A2a-Aglycone

2 G. of C-076 A2a is combined with 40 ml. of a 1% (volume/volume) of solution of concentrated sulfuric acid in methanol. The reaction mixture is stirred at room temperature for 17 hours and diluted with 300 ml. of chloroform. The mixture is washed once with 30 ml. of saturated sodium bicarbonate solution, once with 30 ml. saturated sodium chloride solution, dried over magnesium sulfate and evaporated to dryness in vacuo. 5 Ml. of methanol is added to the residue and allowed to stand at room temperature overnight. Cooling of the mixture in ice causes the slow precipitation of crystals. A supernatant is removed and the solid crystals washed twice with 1 ml. of cold methanol affording 340 mg. of a white solid. The mother liquor and washings are evaporated down to a volume of about 2 ml. and allowed to stand affording an additional crop to crystals. 630 Mg. of a white solid is obtained which is combined with the first batch of crystals and 8 ml. of methanol and evaporated to a volume of 2.5 ml. and allowed to stand for several hours. 910 Mg. of an off white solid is obtained which mass spectrometry identifies as C-076 A2a-aglycone.

PREPARATION 3 C-076-B2a aglycone

2 G. of C-076-B2a is combined with 40 ml. of a 1% solution of concentrated sulfuric acid in methanol (volume/volume). The reaction mixture is stirred at room temperature for 17 hours. 300 Ml. of chloroform is added followed by 30 ml. of an aqueous saturated sodium bicarbonate solution. The layers are separated and the organic layer washed with 30 ml. of saturated sodium chloride solution, dried over magnesium sulfate and evaporated to dryness in vacuo. 5 Ml. of methanol is added to dissolve the residue and the mixture allowed to stand at room temperature and then cooled in an ice bath, whereupon crystallization occurred. The supernatant is removed and the residue washed twice with 1 ml. portions of cold methanol and the solid crystals dried overnight and then in vacuo at 35 C. affording 1.0 g. of white crystals. A second crop is obtained by evaporating the mother liquors to a volume of 2 ml. and allowing to stand overnight at room temperature. 2 Ml. of methanol is added and the mixture aged in an ice bath affording 140 mg. of a yellow solid. The two solid fractions are combined and dissolved in boiling methanol, about 30 ml. of methanol is required. The solution is filtered hot and concentrated to a volume of about 20 ml. in vacuo whereupon solids begin to precipitate. The solution is filtered hot and the solid materials washed with methanol affording 340 mg. of a white solid. The filtrates are boiled down to a volume of about 8 ml. and set aside to crystallize at room temperature affording 433 mg. of a white solid. Mass spectrometry shows the two fractions to be identical and to be identified as C-076-B2a-aglycone.

PREPARATION 4 C-076-B1a-Aglycone

100 Mg. of C-076 B1a is dissolved in 2.5 ml. of dioxane and combined with 2.5 ml. of a mixture prepared from 0.5 ml. of water, 0.5 ml. of concentrated sulfuric acid and 9.0 ml. of dioxane. The reaction mixture is stirred at room temperature for 17 hours. 50 Ml. of ether and 25 ml. of saturated aqueous sodium bicarbonate is added, the layers separated, and the organic layer washed with water and the water layer extracted with ether. The organic layers are combined, dried over sodium sulfate, and evaporated to dryness. Benzene is added and the solution again evaporated affording 60 mg. of a yellow oil. The oil is chromatographed on a preparative layer chromatography silica gel plate, eluting with a 9:1 mixture of chloroform and tetrahydrofuran affording at an Rf of about 0.35, 16 mg. of C-076 B1a-aglycone, which is identified by 300 MNz nuclear magnetic resonance.

PREPARATION 5 22,23-Dihydro-C-076-A1a

51.0 Mg. of C-076-A1a and 14.4 mg. of tris(triphenylphosphine)rhodium(I)chloride are combined in 3.5 ml. of benzene and hydrogenated for 20 hours at room temperature under atmospheric pressure. The crude reaction mixture is chromatographed on a preparative layer chromatography plate eluting twice with 10% tetrahydrofuran in chloroform. The product is removed from the support using ethyl acetate which is evaporated to dryness and the residue analyzed with 300 MHz nuclear magnetic resonance and mass spectroscopy indicating the preparation of 22,23-dihydro-C-076 A1a.

PREPARATION 6 22,23-Dihydro-C-076 B1a

A solution of 1.007 g. of C-076-B1a, 314 mg. of tris(triphenylphosphine)rhodium(I)chloride and 33 ml. of benzene is hydrogenated for 21 hours at room temperature under 1 atmosphere of hydrogen pressure. The solvent is removed in vacuo and the residue dissolved in a 1:1 mixture of methylene chloride and ethyl acetate and filtered. The filtrate is placed on a column of 60 g. of silica gel eluting with a 1:1 mixture of methylene chloride and ethyl acetate taking 10 ml. fractions. Fractions 14-65 are combined and evaporated to dryness affording 1.118 g. of a solid material which is indicated by high pressure liquid chromatography to be a 60/40 mixture of the hydrogenated product and starting material. The mixture is rehydrogenated in 55 ml. of benzene adding 310 mg. of tris(triphenylphosphine)rhodium(I)chloride and stirring for 21 hours at room temperature under 1 atmosphere of hydrogen pressure. The solvent is removed in vacuo and the residue chromatographed on 80 g. of silica gel using 40:60 mixture of ethyl acetate and methylene chloride as eluant. 10 Ml. fractions are taken and the product appears in fractions 26-80. These fractions are combined and evaporated to dryness in vacuo affording a yellow oil. The oil is dissolved in benzene and lyophilized affording a pale yellow powder which is identified as 22,23-dihydro-C-076-B1a by mass spectrometry and 300 MHz nuclear magnetic resonance 0.976 G. of product is obtained.

PREPARATION 7 22,23-Dihydro-C-076-A1a Aglycone

10.1 Mg. of 22,23-dihydro-C-076 A1a is stirred for 20 hours in 1.1 ml. of 1% sulfuric acid in methanol at room temperature. The reaction mixture is treated as in Preparation 6 affording an oil which is purified by preparative layer chromatography on silica gel eluting with 5% tetrahydrofuran in chloroform. The product is removed from the chromatography plate and lyophilized fom benzene affording 4.2 mg. of a white powder which 300 MHz nuclear magnetic resonance and mass spectrometry indicate to be 22,23-dihydro-C-076-A1a aglycone.

PREPARATION 8 22,23-Dihydro-C-076-B1a-Aglycone

0.486 G. of 22,23-dihydro-C-076-B1a is added to a stirred solution 50 ml. of 1% sulfuric acid in methanol and the reaction mixture stirred for 13 hours at room temperature. The reaction mixture is diluted with 250 ml. of methylene chloride and washed with 50 ml. of saturated aqueous potassium bicarbonate and 50 ml. of water. The aqueous layer is washed twice with 20 ml. portions of methylene chloride and the combined organic phases are dried with saturated brine and sodium sulfate and evaporated to dryness in vacuo affording 0.480 g. of a pale yellow foam. The foam is dissolved in 4 ml. of methylene chloride and placed on 4 preparative layer chromatography silica gel plates and eluted 4 times with 4% tetrahydrofuran and chloroform. The product is recovered from the silica gel plates affording an oily residue which is lyophilized from benzene affording 255.8 mg. of a white solid. Traces of methyl oleandroside are indicated to be present in the solid material. The white solid is then lyophilized again from benzene and placed under high vacuum for 20 hours to remove the impurity affording 22,23-dihydro-C-076-B1a-aglycone.

PREPARATION 9

A 250 ml. baffled Erlenmeyer flask containing 50 ml. of the following medium:

______________________________________Lactose              2.0%Distiller's solubles 1.5%Autolyzed yeast, Ardamine pH                0.5%pH-before sterilization                7.0______________________________________

is inoculated with the contents of one frozen vial of Streptomyces avermitilis MA 4848 and incubated on a rotary shaker at 28 C. for 24 hours at 150 RPM.

10 Ml. of the above fermentation media is employed to inoculate 500 ml. of the same medium as above in a 2 liter baffled Erlenmeyer flask. The fermentation media is incubated at 150 RPM on a rotary shaker at 28 C. for 24 hours.

All of the foregoing media is employed to inoculate 467 liters of the following media in a 756 liter stainless steel fermentor:

______________________________________Lactose                2.0%Distiller's solubles   1.5%Autolyzed yeast, Ardamine pH                  0.5%Polyglycol 2000        0.32 ml/literpH-before sterilization                  7.0______________________________________

The fermentation media is incubated at 28 C. for 40 hours with an air flow 10 cubic feet per minute and an agitation rate 130 RPM.

230 Liters of the above media is employed to inoculate 4,310 liters of the following medium in a 5,670 liter stainless steel fermentor:

______________________________________Dextrose               4.5%Peptonized milk        2.4%Autolyzed yeast, Ardamine pH                  0.25%Polyglycol 2000        2.5 ml/literpH-before sterilization                  7.0______________________________________

The fermentation continues for 144 hours at 26 C. with an air flow rate of 54.3 cubic feet per minute and agitation of 120 RPM.

The fermentation media are filtered and teh mycelial filter cake washed with about 550 liters of water, the filtrate and washings are discarded. The filter cake is agitated with about 1500 liters of acetone for about one hour and filtered. The filter cake is washed with a mixture of about 150 liters of acetone and 40 liters of deionized water affording about 2000 liters of extract.

The foregoing fermentation and extraction is repeated on the same scale affording s further 2000 liters of acetone extract which is combined with the first extract and evaporated to a volume of about 800 liters. The pH of the concentrate is adjusted to about 4.7 with concentrated hydrochloric acid and combined with about 800 liters of methylene chloride. The combined solvents are agitated for about 4 hours and separated. The aqueous layer is combined with an additional 800 liters of methylene chloride and agitated for about 4 hours. The layers are separated and each methylene chloride extract separately treated with about 10 kilograms of Super-Cel and filtered. Both extracts are evaporated to a combined volume of about 60 liters.

PREPARATION 10

The 60 liter solution of C-076 in methylene chloride of the previous example is concentrated to dryness in vacuo and the residue is combined 3 times with 60 liter portions of methanol and evaporated to dryness to remove any residual methylene chloride. The final methanol concentrate volume is approximately 36 liters. The methanol solution is stored overnight and filtered. The filter cake is washed with 40 liters of fresh methanol and the methanol filtrates and washings are combined. The methanol solution is combined with 95 liters of ethylene glycol and 130 liters of heptane. The 2 layer solution is agitated for 5 minutes and the lower layer (ethylene glycol and methanol) is separated. The heptane solution is washed with a mixture of 20 liters of ethylene glycol and 6.3 liters methanol. After five minutes of agitation, the lower layer is separated and combined with the first ethylene glycol/methanol extract. An equal volume of water (approximately 150 liters) containing 79 g. of salt per liter is added to the ethylene glycol/methanol extracts. This solution is extracted with 150 liters of ethyl ether with agitation for 5 minutes. The ether layer is washed with 75 liters of water (1/2 volume) and agitated for 5 minutes and the layers separated. This procedure is repeated an additional 2 times (the final water wash contains 20 g. of salt per liter) affording a final ether layer volume of 110 liters. The ether layer is concentrated in vacuo, to a minimum volume, keeping the temperature less than 25 C. 40 Liters of methylene chloride is added to the residue and the solution is evaporated to dryness. This procedure is repeated and the final residue concentrated in vacuo at 50 C. to dryness.

PREPARATION 11

A 30 centimeter diameter column is prepared with a layer of 34 kilograms of activated alumina followed by a layer of 34 kilograms of activated carbon in a solution of methylene chloride. The residue from the previous example is dissolved in methylene chloride to a volume of 34 liters and applied to the column and eluted with 34 liters of methylene chloride, these fractions are discarded. A 3% solution of isopropanol and methylene chloride (20.8 liters of isopropanol and 660 liters of methylene chloride) is applied to the column and eluted in approximately 200 liter fractions. The combined isopropanol and methylene chloride fractions are evaporated in vacuo at a bath temperature of about 60 C. to a volume of about 20 liters. The bath temperature is reduced to about 45 C. and the extract is evaporated to dryness in vacuo. The residue is dissolved in 10 parts methylene chloride, 10 parts hexane and one part methanol to a final volume of 15 liters. This solution is applied directly to the Sephadex LH-20 column of the next example.

PREPARATION 12

A 30 centimeter diameter column is prepared in methanol with 36 kilograms of Sephadex LH-20 (available from Pharmacia Fine Chemicals, 800 Centennial Avenue, Piscataway, N.J. 08854) and washed with a solvent consisting of 10 parts methylene chloride, 10 parts hexane and one part methanol. One-fourth of the C-076 solution of Example 10 is applied to the column and the column eluted at a rate of 250 ml. per minute. Two 20 liter forecuts are collected and discarded followed by 20 two liter rich cuts (identified as fractions 1-20), followed by a single 20 liter tail cut, which is discarded. Fractions 1-8 are found to contain the C-076 A compounds and fractions 9-20 are found to contain the C-076 B compounds.

PREPARATION 13

The process of Preparation 12 is repeated on the same scale three more times and all of the fractions containing the C-076 B components (fractions 9-20) are combined and evaporated to dryness, affording 818 g. of crude mixed C-076 B components. The sample is found to contain 55% C-076 B1 and 39% of C-076 B2. 680.5 G. of this sample is dissolved in 2 liters of methylene chloride and placed in a 22 liter three neck round bottom flask followed by the addition of 13.6 liters of methanol. The methylene chloride is removed by distillation. 13.6 Liters of ethylene glycol is added as the methanol is being distilled under reduced pressure. The rate of distillation is maintained such that the temperature of the solution did not go below 65 C. When the addition of the ethylene glycol is complete, the solution is allowed to cool at 5 C. for sixteen hours. The crystals are filtered and washed with 1 liter of cold ethylene glycol. The crystals are then redissolved in 2 liters of methylene chloride the solution placed in a 22 liter three necked round bottom flask. The procedure described above is repeated twice. The first time 12.5 liters each of methanol and ethylene glycol is employed and the second time 13.6 liters each of methanol and ethylene glycol is employed. The final crystals are washed with 1 liter of cold ethylene glycol and 1 liter of water. The crystals are dissolved in 4 liters of water and dried by filtering through sodium sulfate. The benzene solution is concentrated to a volume of 2 liters and lyophilized affording 241.2 gm. of a white powder consisting of 98% C-076 B1 and 1% of C-076 B2.

The mother liquors (22 liters) from the first two crystallizations above are combined and diluted with 22 liters of water. The aqueous solution is extracted with 60 liters of toluene and again with 15 liters of toluene. The toluene extract is then washed with 48 liters of water. The organic phase is filtered through Super-Cel to remove any residual water and evaporated affording 336 gm. of solid material consisting of 79% C-076 B2 and 16% C-076 B1 compounds.

PREPARATION 14

In the four Sephadex LH-20 columns of the procedure of Preparation 12, fractions 1-8 contain the C-076 A compounds and are combined. By HPLC analysis the mixture is found to contain 252 g. of C-076 A2a, 16 g. of A2b, 94 g. of A1a and 24 g. of A1b. The material is dissolved in a solvent system consisting of hexane:toluene:methanol in the proportion of 6:1:1 and applied to the Sephadex LH-20 column of the same dimensions as the one used in Preparation 12 in the above solvent. Fractions are collected at the rate of 250 ml. per minute and a 20 liter forecut is collected and discarded. Further elution affords 2 additional 20 liter forecuts which are also discarded and 50 four liter rich cuts which contain C-076 A compounds. Fractions 3-8 are found to contain predominately C-076 A1 components (40.2 g. A1a and 6.7 g. A1b), and fractions 29-36 are found to contain C-076 A2 compounds (117.2 g. A2a and 7.35 g. of A2b). Fractions 9-28 contain a mixture of C-076 A1 and A2 compounds.

PREPARATION 15

A sample of 150 g. of C-076 B1 from Preparation 13 is dissolved in 3 liters of a solvent mixture of hexane:toluene:methanol in the ratio of 3:1:1. The solution is passed through a column of Sephadex LH-20 (of the same dimensions as the one used in Preparation 12) in the above solvent taking fractions at the rate of 250 ml. per minutes. After two 20 liter portions of the solvent mixture are collected and discarded, forecut of 10 liters is taken and discarded. Then 30 richcuts of 2 liters each are taken. Fractions 1-13 and 25-30 are discarded. Fractions 14-16 are combined and contain 80 g. of predominately C-076 B1a. Fractions 22-24 are combined and contain 6.7 g. of predominately C-076 B1 b. Fractions 17-21 contain a mixture of C-076 B1a and B1b.

Fractions 17-21 above are combined and concentrated and passed through a Sephadex LH-20 column with the same solvent system as above. Three 20 liter forecuts are taken and discarded. Richcuts are then taken as follows: 5 cuts of 2 liters each (fractions 1-5); 20 cuts of 1 liter each (fractions 6-25); and 10 cuts of 2 liters each (fractions 26-35). Fractions 1-15 are discarded; fractions 16-21 contain 13.5 g. of C-076 B1 a and 0.4 g. of C-076 B1b; fractions 22-26 contain 44 g. of C-076 B1a and 0.13 g. of C-076 B1b; fractions 27-30 contain 10.2 g. of C-076 B1a and 0.8 g. of C-076 B1b.

PREPARATION 16

A mixture of all 8 C-076 components are chromatographed on a high pressure liquid chromatography column 4 mm.30 cm. packed with 10 micron μ Bondapak C18 silica gel (available from Waters Associates Inc., Maple Street, Milford, Mass. 01757) eluting with 85:15 (v/v) methanol:water at a constant 40 C. At a flow rate of 1.2 ml. per minute all eight compounds are separated and the elution volumes, which under the foregoing constant conditions are characteristic of the individual compounds are as follows:

______________________________________     Elution Volume (Ve) Ml______________________________________C-076 B2 b       5.90C-076 B2 a       6.52C-076 A2 b       7.12C-076 A2 a       7.88C-076 B1 b       8.36C-076 B1 a       9.60C-076 A1 b       10.24C-076 A1 a       11.88______________________________________

The separation of C-076 "b" components from the respective "a" components is accomplished using techniques such as high pressure liquid chromatography. An absolute methanol solution of 30 microliters of a mixture of C-076 A1a and A1b, estimated to contain 30 micrograms of C-076 A1b is placed on a 3250 mm. high pressure liquid chromatography column containing Spherisorb 5 micron ODS (available from Spectra Physics) as packing. The column is eluted with 85:15 methanol-water at a rate of 0.15 ml./min. The elution of the products are followed by observing the ultraviolet absorption of the eluent and collecting the individual components at the outlet of the UV monitor. 30 Micrograms of C-076 A1b is recovered in this manner.

Patent Citations
Cited PatentFiling datePublication dateApplicantTitle
US3950360 *Sep 4, 1973Apr 13, 1976Sankyo Company LimitedAntibiotic substances
Non-Patent Citations
Reference
1 *Jour. of Antibiotics 29(6) Jun. 1976, pp. 76 35 to 76 42 and pp. 76 14 to 76 16.
2Jour. of Antibiotics 29(6) Jun. 1976, pp. 76-35 to 76-42 and pp. 76-14 to 76-16.
3 *Mishima et al., Tetrahedron Letters, 10, pp. 711 714, 1975.
4Mishima et al., Tetrahedron Letters, 10, pp. 711-714, 1975.
5 *Sankyo Co., Derwent Abstracts, 76268w/46.
Referenced by
Citing PatentFiling datePublication dateApplicantTitle
US5001145 *Jan 27, 1989Mar 19, 1991American Cyanamid CompanyMacrolide compounds
US5082933 *Jan 10, 1990Jan 21, 1992Bristol-Myers Squibb Co.Antitumor antibiotic BMY-42448
US5122618 *Oct 17, 1990Jun 16, 1992Ciba-Geigy CorporationInsecticides and parasiticides
US5149832 *Sep 12, 1986Sep 22, 1992American Cyanamid CompanyAnthelmintic, insecticide, ectoparasicide, nematocide and acaricide
US5162363 *Mar 18, 1992Nov 10, 1992Merck & Co., Inc.23-nor-23-thia avermectin analogs are active anthelmintic agents
US5171742 *Oct 15, 1991Dec 15, 1992Merck & Co., Inc.Parasiticides, insecticides
US5240915 *Oct 15, 1991Aug 31, 1993Merck & Co., Inc.Avermectin derivatives
Classifications
U.S. Classification549/264, 536/7.1
International ClassificationC07F7/18, A01N43/90, C07H19/01, C12P19/62
Cooperative ClassificationC12P19/623, C07H19/01, A01N43/90, C12R1/465, C07F7/1856
European ClassificationC07H19/01, A01N43/90, C07F7/18C4D4D, C12P19/62A, C12R1/465